Physiomics Share News (PYC)
PYC Share
PYC Share
PYC Share
PYC Share
PYC
PYC Share
PYC Level 2
PYC Live
PYC Broker
PYC Directors
PYC Financial
PYC
PYC Short
PYC
Last checked at -
Thu, 28th Nov 2013 15:10
LONDON (Alliance News) - Shares in Physiomics PLC jumped 19% Thursday after it launched its drug combinations and regimens database DrugCard.
DrugCard collects publicly available pre-clinical and clinical drug regimen data into a searchable database.
Shares in the biotechnology company were trading up 19% at 0.190 pence Thursday afternoon.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright © 2013 Alliance News Limited. All Rights Reserved.
EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Physiomics recruits first patient for Partner study
Read moreTRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy
Read moreAIM WINNERS & LOSERS: Arkle finds gold; Staffline raises cash
Read more
(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it has been awarded two further contracts by existing client Bicycle Therapeutics.
Read moreAIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins
Read morePhysiomics secures follow-on contract from Merck KgaA
Read more(Sharecast News) - Drug development consultancy Physiomics has been awarded a further contract with a leading science and technology company Merck.
Read moreIN BRIEF: Physiomics wins first contract from Numab Therapeutics
Read more(Sharecast News) - Consultancy firm Physiomics said on Tuesday that it has been awarded a first contract with new client Numab Therapeutics.
Read morePhysiomics says full-year results to disappoint market forecasts
Read moreAIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake
Read more(Sharecast News) - Technology-based solutions provider Physiomics said on Monday that total income for the financial year ending 30 June was likely to be below market expectations due to both Covid-19 related project delays and an increased focus on longer-term value-generating activities.
Read moreAIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes
Read more
Last checked at